United States Biotechnology & Medical Research

Acrivon Therapeutics Inc (ACRV)

Track

Acrivon Therapeutics Inc. experienced two insider trading transactions over the past ninety days, both involving sales by executives. Chief Financial Officer Adam D. Levy and Chief Legal Officer Mary Miller offloaded shares totaling approximately 2,801 USD. These disposals occurred following the company's May earnings report, amid a period where the stock price declined by 11.5 percent.
Ticker: ACRV Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Acrivon Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.3
Levy Adam D. Chief Financial Officer Officer
Transaction date
Sale
Price
131.54
Quantity 32,631 +19.5%
Value US$3,078,882
3.2
Miller Mary Chief Legal Officer Officer
Transaction date
Sale
Price
69.94
Quantity 63,647 +39.4%
Value US$576,527
1.3
Levy Adam D. Chief Financial Officer Officer
Transaction date
Purchase
Price
80.22
Quantity 61,701 +15.3%
Value US$2,175,974
1.7
Blume-Jensen Peter President and CEO Executive Director
Transaction date
Purchase
Price
1.68
Quantity 49,000 +2.4%
Value US$82,124
1.5
Devroe Eric Chief Operating Officer Officer
Transaction date
Purchase
Price
1.72
Quantity 10,000 +15.3%
Value US$17,218
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.41
Quantity 437,881 -11.4%
Value US$617,412
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.41
Quantity 250,000 -6.1%
Value US$352,500
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.56
Quantity 215,283 -5.0%
Value US$335,841
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.95
Quantity 1,054,669 -19.7%
Value US$2,056,605
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
8.50
Quantity 2,353,000 +78.2%
Value US$20,000,500
1.5
Chione Ltd Large shareholder
Transaction date
Sale
Price
12.93
Quantity 16 -0.0%
Value US$207
1.5
Chione Ltd Large shareholder
Transaction date
Sale
Price
12.14
Quantity 2,056 -0.1%
Value US$24,960
1.5
Chione Ltd Large shareholder
Transaction date
Sale
Price
12.13
Quantity 893 -0.0%
Value US$10,832
1.5
Chione Ltd Large shareholder
Transaction date
Sale
Price
12.30
Quantity 3,000 -0.1%
Value US$36,900
1.5
Chione Ltd Large shareholder
Transaction date
Sale
Price
12.34
Quantity 2,000 -0.1%
Value US$24,680
1.5
Chione Ltd 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
12.44
Quantity 219,259
Value US$2,727,594
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.50
Quantity 3,389,500 +340.8%
Value US$42,368,750
1.5
Chione Ltd Large shareholder
Transaction date
Purchase
Price
12.50
Quantity 400,000 +11.6%
Value US$5,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-06 2026-08-04 S Sale
1.3
Levy Adam D.

Chief Financial Officer

Officer
32,631 +19.5%
131.54
US$3,078,882 		32,631 +19.5% 131.54 US$3,078,882
2026-07-23 2026-07-21 S Sale
3.2
Miller Mary

Chief Legal Officer

Officer
63,647 +39.4%
69.94
US$576,527 		63,647 +39.4% 69.94 US$576,527
2026-01-16 2026-01-14 B Purchase
1.3
Levy Adam D.

Chief Financial Officer

Officer
61,701 +15.3%
80.22
US$2,175,974 		61,701 +15.3% 80.22 US$2,175,974
2026-01-16 2026-01-14 B Purchase
1.7
Blume-Jensen Peter

President and CEO

Executive Director
49,000 +2.4%
1.68
US$82,124 		49,000 +2.4% 1.68 US$82,124
2026-01-15 2026-01-13 B Purchase
1.5
Devroe Eric

Chief Operating Officer

Officer
10,000 +15.3%
1.72
US$17,218 		10,000 +15.3% 1.72 US$17,218
2025-05-01 2025-05-01 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
298,886 -8.8%
1.34
US$400,507 		298,886 -8.8% 1.34 US$400,507
2025-05-01 2025-04-30 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
437,881 -11.4%
1.41
US$617,412 		437,881 -11.4% 1.41 US$617,412
2025-04-29 2025-04-29 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
250,000 -6.1%
1.41
US$352,500 		250,000 -6.1% 1.41 US$352,500
2025-04-29 2025-04-28 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
215,283 -5.0%
1.56
US$335,841 		215,283 -5.0% 1.56 US$335,841
2025-04-29 2025-04-25 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
1,054,669 -19.7%
1.95
US$2,056,605 		1,054,669 -19.7% 1.95 US$2,056,605
2024-04-15 2024-04-11 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
2,353,000 +78.2%
8.50
US$20,000,500 		2,353,000 +78.2% 8.50 US$20,000,500
2023-06-28 2023-06-26 S Sale
1.5
Chione Ltd
Large shareholder
16 -0.0%
12.93
US$207 		16 -0.0% 12.93 US$207
2023-06-20 2023-06-15 S Sale
1.5
Chione Ltd
Large shareholder
2,056 -0.1%
12.14
US$24,960 		2,056 -0.1% 12.14 US$24,960
2023-06-14 2023-06-14 S Sale
1.5
Chione Ltd
Large shareholder
893 -0.0%
12.13
US$10,832 		893 -0.0% 12.13 US$10,832
2023-06-14 2023-06-13 S Sale
1.5
Chione Ltd
Large shareholder
3,000 -0.1%
12.30
US$36,900 		3,000 -0.1% 12.30 US$36,900
2023-06-14 2023-06-12 S Sale
1.5
Chione Ltd
Large shareholder
2,000 -0.1%
12.34
US$24,680 		2,000 -0.1% 12.34 US$24,680
2023-06-12 2023-06-12 PrS Proposed sale
1.5
Chione Ltd

10% Stockholder

Large shareholder
219,259
12.44
US$2,727,594 		219,259 12.44 US$2,727,594
2022-11-21 2022-11-17 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
3,389,500 +340.8%
12.50
US$42,368,750 		3,389,500 +340.8% 12.50 US$42,368,750
2022-11-21 2022-11-17 B Purchase
1.5
Chione Ltd
Large shareholder
400,000 +11.6%
12.50
US$5,000,000 		400,000 +11.6% 12.50 US$5,000,000
Explore more

More insider trading research around Acrivon Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America